A

ALDX

Aldeyra Therapeutics Inc

1.780

-0.020-1.11%
Pre Market: 1.830  +0.050  +2.81%04:10 04/21 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE1.788/1.800
TODAY RANGE1.751-1.815
VOL2.25K
MARKET CAP107.13M
52 WEEK RANGE1.070-6.18
AVG VOL (3M)3.05M
% TURNOVER1.63%
TURNOVER0
P/E (TTM)-3.1583
% RANGE3.54%
EPS(TTM)-0.5636
P/E(FORWARD)-4.0455
P/B2.420
BVPS0.7355
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP96.24M
SHARES OUTSTANDING60.18M
NEXT EARNINGS05/12-05/18
FREE FLOAT54.07M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Same Industry
Name/Symbol
Change%
Price

ALDX

--

再生元製藥

REGN

-0.30%
748.31

GRDX

--

B

BIONTECH

BNTX

+0.78%
102.92

U

United Therapeutics Corp.

UTHR

+1.36%
588.38

S

SIGA科技

SIGA

+2.59%
4.760

VRTX

--

M

Moderna

MRNA

-1.76%
53.72

CRL

--

M

Medpace控股

MEDP

+0.96%
520.60

TLPH

--

ICLR

--

CBPO

--

IQV

--

M

MOLECULAR PARTNERS AG

MOLN

+0.60%
4.205

ARCT

--

PRAH

--

GILD

--

A

Aptevo Therapeutics Inc

APVO

-5.88%
5.28

因塞特醫療

INCY

+2.62%
97.82

BSTC

--

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.